We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Mar 2022
  • Code : CMI4955
  • Pages :162
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Scars form as a result of the healing process of the body. The body creates tissue to repair damaged skin and fill gaps caused by an injury. Accident, burns, surgery, acne, and illness can develop scars on the body.

To close a wound quickly after an incision, skin cells multiply and synthesize the elements that surround them, such as collagen or elastin. The scar is formed as a result of the formation of new fibrous tissue. Any surgical incision results in the formation of a scar, the final appearance of which will be determined by a number of factors, including its anatomical site, operative techniques, sutures, intrinsic patient-related factors, extrinsic factors such as environmental factors.

U.S. Post-Surgical Scar Treatment Market - Impact of the Coronavirus (COVID-19) Pandemic

The number of surgeries such as open heart surgery, C-sections, appendectomy, mastectomy, or knee replacement surgery can cause scars on the body. In 2020, the COVID-19 pandemic disrupted delivery of healthcare services around the U.S., including delays in various elective surgical procedures. For instance, according to an article published in JAMA Network, Journal of the American Medical Association is a peer-reviewed medical journal, in December 2021, a cohort study of pediatric and adult patients from January 1, 2019 to January 30, 2021, undergoing surgery in the U.S. was conducted. Moreover, the study's findings revealed a 48.0% decrease in total surgical procedure volume immediately following the March 2020 recommendation to cancel elective surgical procedures. Thus, the preceding example suggests that there was a decrease in the overall number of surgical procedures performed in the U.S., which may have resulted in a decrease in the treatment of post-surgical scars on the body. Therefore, the COVID-19 impact is expected to hinder the growth of the U.S. post-surgical scar treatment market over the forecast period.

The U.S. post-surgical scar treatment market is estimated to be valued at US$ 2,680.1 Mn in 2022, and is expected to exhibit a CAGR of 10.1% over the forecast period (2022-2030).

Increasing number of surgical procedures in the U.S. is the major factor that is expected to drive growth of the U.S. post-surgical scar treatment market over the forecast period.

The increasing number of surgical procedures in the U.S. population is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. According to the National Center for Biotechnology Information (NCBI), 2020, the following graph shows the number of plastic surgeries carried out in the year 2017, 2018, 2019, and 2020, in the U.S.

Figure 1: Number of Plastic Surgeries in the U.S.

U.S. POST-SURGICAL SCAR TREATMENT MARKET

To learn more about this report, request a free sample copy

Increasing number of product launches by the market players is expected to drive the market growth over the forecast period

Market players are indulged in launching number of innovative products for the treatment of scars. This is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. For instance, on November 11, 2021, Estas Beauty, a manufacturer of skin care products, launched three products i.e., ‘Morning Massage’ cleansing oil with vitamin E & primrose; a ‘Daily Dose’ vitamin E & C cream serum; and ‘Sleep Salve’ silicone & Vitamin E mask. All the three products has silicone, which increases hydration and reduces collagen production, itching, and discomfort. The product is used for patients who undergo surgical procedures and develop scarring.

U.S. Post-Surgical Scar Treatment Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 2,680.1 Mn
Historical Data for: 2017 to 2021 Forecast Period: 2022 to 2030
Forecast Period 2020 to 2030 CAGR: 10.1% 2030 Value Projection: US$ 5,769.4 Mn
Geographies covered:
  • North America: U.S. 
Segments covered:
  • By Product Type: Silicone sheets & Patches, Surgical tapes, Strips, Gels & Creams, Others
  • By Channel: OTC, Rx
  • By Scar Type: Atrophic Scars, Hypertrophic Scars, Keloid Scars, Contracture Scars
  • By Surgery Type: Caesarean Section, Joint Replacement, Appendectomy, Heart Surgery, Breast surgery, Others
  • By End User: Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals
Companies covered:

Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.

Growth Drivers:
  • Increasing number of surgical procedures in the U.S. population
  • Increasing number of product launches by the market players
Restraints & Challenges:
  • Availability of alternative treatments such as laser treatment

Figure 2: U.S. Post-Surgical Scar Treatment Market Share (%) Analysis, By Product Type, 2022

U.S. POST-SURGICAL SCAR TREATMENT MARKET

To learn more about this report, request a free sample copy

U.S. Post-Surgical Scar Treatment Market – Restraints

The availability of other treatments such as laser treatment for post-surgical scars is expected to hamper growth of the U.S. post-surgical scar treatment market over the forecast period. According to the article published in the American Society of Plastic Surgeons: 2020, laser therapy is a safe and effective treatment for scars. According to the same source, dermatologists can use a laser to reduce a scar's appearance and minimize pain and itching. Laser treatment can also prevent scars from forming after surgery. Laser treatment also helps to stimulate new and healthy skin growth.

U.S. Post-Surgical Scar Treatment Market – Competitive Landscape

Major players operating in the U.S. post-surgical scar treatment market include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.

Frequently Asked Questions

The U.S. post-surgical scar treatment market is expected to exhibit a CAGR of 10.1% during the forecast period (2022-2030).

The market is estimated to be valued at US$ 2,680.1 Mn in 2022.

The prominent players operating in the U.S. post-surgical scar treatment market include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.

The market is expected to be valued at US$ 5,769.4 Mn in 2030.

An increasing number of surgical procedures in the U.S. population, and increasing number of product launches by the market players are some of the driving factors, which are expected to drive growth of the market.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo